Manju Chandran
Overview
Explore the profile of Manju Chandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuggle N, Laslop A, Rizzoli R, Al-Daghri N, Alokail M, Balkowiec-Iskra E, et al.
Drugs
. 2025 Feb;
85(3):343-360.
PMID: 39969778
Osteoporosis and osteoarthritis are key diseases of musculoskeletal ageing and are increasing in prevalence and burden with the progressively ageing population worldwide. These conditions are thus particularly common in 'the...
2.
Sng G, Reginster J, Alokail M, Chandran M
Osteoporos Sarcopenia
. 2025 Jan;
10(4):131-144.
PMID: 39835326
Osteoporosis in men remains a significantly underrecognized condition, with notable differences in bone mineral density (BMD) and fracture risk between Asian and Western populations. Despite 30% of hip fractures globally...
3.
Nagendra L, Chandran M, Reginster J, Bhadada S, Bhattacharya S, Dutta D, et al.
Osteoporos Int
. 2024 Dec;
36(2):311-322.
PMID: 39730734
Purpose: Osteoporosis represents a significant public health challenge in India, with an increasing economic burden due to the aging population. This study evaluated the cost-effectiveness of using fracture risk assessment...
4.
Bailey C, Chandran M, Gale R, Narendran N, Talks J, McGoey H, et al.
Eye (Lond)
. 2024 Dec;
PMID: 39719502
Objectives: The 36-month XTEND (NCT03939767) multicentre, observational, prospective study examined the effectiveness of proactive treatment regimens of intravitreal aflibercept (IVT-AFL) 2 mg in treatment-naïve patients with neovascular age-related macular degeneration...
5.
Jha D, Chandran M, Hong N, Rhee Y, Baek S, Ferguson S, et al.
J Bone Metab
. 2024 Dec;
31(4):296-315.
PMID: 39701109
Background: This review explores the discriminative ability of fracture risk assessment tool (FRAX) in major osteoporotic fracture (MOF) and hip fracture (HF) risk prediction and the densitometric diagnosis of osteoporosis...
6.
Bajaj P, Nagendra L, Bajaj A, Samuel M, Chandran M
Osteoporos Int
. 2024 Nov;
36(2):193-224.
PMID: 39607489
Background: Yoga's effects on interconnected bone health parameters viz balance, falls, fear of falling (FOF), bone mineral density (BMD), and bone turnover markers (BTMs) in healthy individuals are unclear. We...
7.
Paccou J, Yavropoulou M, Naciu A, Chandran M, Messina O, Rolvien T, et al.
Eur J Endocrinol
. 2024 Nov;
191(6):G1-G17.
PMID: 39556468
Introduction: This report presents the recommendations of the European Calcified Tissue Society (ECTS) for the prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) in adults. Our starting point was that the...
8.
Leungsuwan D, Chandran M
Drugs
. 2024 Aug;
84(9):1111-1134.
PMID: 39103693
Bone fragility is a serious yet under-recognised complication of diabetes mellitus (DM) that is associated with significant morbidity and mortality. Multiple complex pathophysiological mechanisms mediating bone fragility amongst DM patients...
9.
Chandra S, Raimondi R, Lim A, Mohan A, Melmane S, Menon G, et al.
Eye (Lond)
. 2024 Jul;
38(15):3005-3010.
PMID: 38971923
Purpose: To evaluate the effect of four versus three loading aflibercept injections on macular fluid resolution and visual acuity (VA) in exudative neovascular AMD (nAMD). Methods: Multicentre, retrospective cohort study...
10.
Pervez A, Chandran M, Khan A
J Pak Med Assoc
. 2024 Jul;
74(6):1202-1203.
PMID: 38949005
No abstract available.